Culmination Bio and BillionToOne partner to advance cancer diagnosis
Both will validate the clinical performance of two new diagnostic tests for regulatory submission
Read More
Tag: BillionToOne
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
